Combinatietherapie bij reumatoide artritis [Combination Therapy in Rheumatoid Arthritis]
Prioriteiten voor toekomstig onderzoek [Priorities for Future Research]
ResearchPublished 2001
Combinatietherapie bij reumatoide artritis: Prioriteiten voor toekomstig onderzoek [Combination Therapy in Rheumatoid Arthritis: Priorities for Future Research]
Topics
Document Details
- Copyright: RAND Corporation
- Availability: Web Only
- Year: 2001
- Pages: 200
- DOI: https://doi.org/10.7249/MR1373
- Document Number: MR-1373-RE/CVZ
Citation
RAND Style Manual
van het Loo, Mirjam, Ineke van Beusekom, Pieter Bots, Renee Allaart, Catherine MacLean, Ferdinand Breedveld, and James P. Kahan, Combinatietherapie bij reumatoide artritis [Combination Therapy in Rheumatoid Arthritis]: Prioriteiten voor toekomstig onderzoek [Priorities for Future Research], RAND Corporation, MR-1373-RE/CVZ, 2001. As of June 28, 2026: https://www.rand.org/pubs/monograph_reports/MR1373.html
Chicago Manual of Style
van het Loo, Mirjam, Ineke van Beusekom, Pieter Bots, Renee Allaart, Catherine MacLean, Ferdinand Breedveld, and James P. Kahan, Combinatietherapie bij reumatoide artritis [Combination Therapy in Rheumatoid Arthritis]: Prioriteiten voor toekomstig onderzoek [Priorities for Future Research]. Santa Monica, CA: RAND Corporation, 2001. https://www.rand.org/pubs/monograph_reports/MR1373.html.
Research conducted by
The research described in this report was performed within RAND Europe.
This publication is part of the RAND monograph report series. The monograph report was a product of RAND from 1993 to 2003. RAND monograph reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.